Bristol Myers Squibb partners with Chai Discovery on AI antibody design

Aug 20, 2026 · Issue 3 · 3 sources, 3 articles

Chai Discovery announced a strategic collaboration with Bristol Myers Squibb on AI-driven antibody design on 20 August.

Who is affected and how

pharmaceuticals

Large companies increasingly rely on external AI biotech partners for antibody design.

Sources

• Bristol Myers Squibb Partners with Chai Discovery for AI Antibody Design - HIT Consultanthitconsultant.net · Aug 20, 2026
• Chai tees up Bristol Myers Squibb AI antibody discovery collab - Fierce Biotechfiercebiotech.com · Aug 20, 2026
• Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery - BioSpacebiospace.com · Aug 20, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.